Alain Labbe Email

Research Director . MicroSintesis

Current Roles

Employees:
16
Revenue:
$2.5M
About
MicroSintesis wants to change the way the world fights diseases. Our vision is a world having more creative and effective options to fight diseases and their consequences. To do so, we need to look elsewhere. There is a growing body of evidence that supports micro-organisms having the ability to communicate with one another. Quorum sensing is the source of microbiome's balance and helps avoid dysbiosis leading to diseases or infections. MicroSintesis wants to revolutionize human and animal welfare through harnessing microbiome's full potential. Amongst immediate challenges, we find antibiotic resistance. This has become an increasing threat to life. While the emergence of new resistant pathogens is accelerating, the ones already there are strengthening. Medical professionalss want to reduce the use of antibiotics, but evidently will not settle for less effectiveness. MicroSintesis is not just another probiotic company. We go a step ahead, strive for discovery and strongly believe that providing health practitioners with a response to antimicrobial resistance should find its way through science. Our solutions leverage years of worldwide scientific discoveries. We believe that our unique patented metabolite is at the heart of microbiome's communication system. MicroSintesis pioneers the creation of a new generation of science-based microbiome and health technologies. We are committed to lead microbiome's research, discover proven & effective alternative to antibiotics, impact long standing health challenges, improve human and animal welfare and promote access to new and effective health solutions.
MicroSintesis Address
NRC Building 28 Duffy Research Centre
Charlottetown, null
MicroSintesis Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.